Insights

August 4, 2026: Crowell & Moring represented Antares, a nuclear fission energy company developing compact microreactors for defense and space applications, in connection with its $470 million Series C funding round. The round was co-led by Paradigm and Caffeinated Capital, with participation from Point72 Ventures, Shine Capital, Industrious Ventures, and others.

June 10, 2026: A Crowell & Moring team represented Arkaea Media Group, a B2B media company covering the defense, space, and nuclear energy sectors, in its acquisition of Decoding Bio, a research and events company focused on the intersection of AI and biotechnology. Decoding Bio publishes a research newsletter with more than 10,000 subscribers and hosts the annual AI x Bio Summit.

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF).